{"id":94,"date":"2023-12-22T06:50:36","date_gmt":"2023-12-22T04:50:36","guid":{"rendered":"https:\/\/www.ipsen.com\/be\/?page_id=94"},"modified":"2024-04-10T11:08:58","modified_gmt":"2024-04-10T09:08:58","slug":"oncologie","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/","title":{"rendered":"Oncologie"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101130\/03-1_Sciences-Oncology_Module-Banner_1920X280.jpg)\">\n        <div class=\"container content-sec\" role=\"main\" id=\"main\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/www.ipsen.com\/be\/fr\/\">Accueil<\/a><\/li><li class=\"breadcrumb-item active\" aria-current=\"page\">Science &#8211; Oncologie<\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">Oncologie<\/h1>\n            <p class=\"visible\">Engagez \u00e0 prolonger et \u00e0 am\u00e9liorer la vie.<\/p>\n        <\/div>\n    <\/section>\n\n\n    <section class=\"title-text \">\n        <div class=\"container\">\n            <div class=\"title-text-inner\" style=\"background-color:#DBEAF5;\">\n                <!-- If heading is enabled then it's visible -->\n                <div class=\"text-head-dash visible\">\n                                            <span class=\"dash\"><\/span> \n                        <p class=\"heading-para\">\n                            UN BUT COMMUN                        <\/p>\n                                        \n                <\/div>\n\n                <!-- If subtitle is enabled then it's visible -->\n                <div class=\"text-head-dash hidden\">\n                                            <h2 class=\"heading-para\">\n                                                    <\/h2>\n                    \n                <\/div>\n                \n                <!-- If description is enabled then it's visible -->\n                <div class=\"text-parbase visible\">\n                    <p><p>Avec plus de 35 ans d&#8217;exp\u00e9rience en oncologie, nous partageons un objectif : prolonger la vie des patients, am\u00e9liorer la sant\u00e9 et cr\u00e9er un impact positif pour les patients et la soci\u00e9t\u00e9.<\/p>\n<\/p>\n                <\/div>\n\n                <!-- If button is enabled then it's visible -->\n                \n            <\/div>\n        <\/div>\n    <\/section>\n\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row \">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 \">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101219\/Module-3_Our-commitment-to-patients_526A1853_02-scaled-1.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 \">\n                        <div class=\" section-content\">\n                                                                                            <h3 class=\"section-head-two\">\n                                        Notre engagement en oncologie                                    <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        Les \u00e9quipes d&#8217;Ipsen en oncologie sont au c\u0153ur de notre mission de prolonger la vie des patients et d&#8217;am\u00e9liorer leur sant\u00e9. Aux c\u00f4t\u00e9s de partenaires qui partagent notre vision, nous concentrons nos efforts sur des cancers cibl\u00e9s pour faire avancer la recher                                    <\/p>\n                                                                                <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->\n\n<!-- Text & Media Block Code -->\n<section class=\"two-col-section text-media-section\">\n    <div class=\"container two-section-innner section-reverse\">\n        <div class=\"response-inner\" style=\"background-image: url('')\">\n            <div class=\"row section-reverse\">\n                <div class=\"col-xs-12 col-sm-12 col-md-6\">\n                                                    <div class=\"img-video-section\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101310\/Module-4-Our-commitment-to-patients_Ipsen-Crewe-Steve-Pointon_700X420-px.jpg\" alt=\"Media Image\" title=\"Media Image\">\n                            <\/div>\n                                        <\/div>\n                <div class=\" col-xs-12 col-sm-12 col-md-6\">\n                    <div class=\"section-content\">\n                        <div class=\"heading-dash\">\n                                                    <\/div>\n                        <p class=\"section-head-two\">\n                            Notre engagement envers les patients                        <\/p>\n                        <p>Le diagnostic d&#8217;un cancer bouleverse une vie. Bien qu&#8217;il existe plus d&#8217;options de traitement que jamais aujourd&#8217;hui, il y a un besoin urgent d&#8217;innovation. Nous sommes r\u00e9solument engag\u00e9s \u00e0 servir les patients atteints de cancers parmi les plus difficiles \u00e0 traiter. Nous travaillons avec plus de 100 associations de patients atteints de cancer dans le monde et soutenons les programmes de sensibilisation \u00e0 des th\u00e9matiques qui sont importantes pour les communaut\u00e9s que nous servons.<\/p>\n                            <a \n                                aria-label=\"Learn more about Notre engagement envers les patients\" \n                                role=\"link\" \n                                class=\"btn-link section-btn cta-visible\"\n                                href=\"https:\/\/www.ipsen.com\/be\/fr\/patients\/\" \n                                target=\"_self\"\n                            > \n                                En savoir plus \n                            <\/a>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n\n\n\n<!--Graphics Cards Carousel Start Here-->\n    <section class=\"graphic-card bgColor-enabled\" style='background: #DBEAF5;' data-displaycards=\"2\">\n        <div class=\"container\">\n            <div class=\"text-graph-inner\">\n                <div class=\"row\">\n                    <!--Graphic info section-->\n                    <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                        <div class=\"text-graph-heading\">\n                            <h2 class=\"charcoal-grey visible\">Chiffres cl\u00e9s<\/h3>\n                            <p class=\"text-graph-para charcoal-grey hidden\"><\/p>\n                        <\/div>\n                    <\/div><!--Graphic info section over here -->\n\n                    <!--Graphic detail section-->\n                    <div class=\"column-2 col-xl-12 col-md-12 col-sm-12\">\n                        <!-- graphic-card carousel start here -->\n                                                    <div class=\"text-graph-carousel\">\n                                <div class=\"glider-contain multiple\">\n                                                                                    <div class=\"text-graph-content-btn\">\n                                                    <button aria-label=\"Pr\u00e9c\u00e9dent\" class=\"glider-graphic-card-prev\"><span><\/span><\/button>\n                                                    <button aria-label=\"Suivant\" class=\"glider-graphic-card-next\"><span><\/span><\/button>\n                                                <\/div>\n                                    \n                                <div class=\"glider-graphic-card\">\n                                                                                                                    <div class=\"text-graphic\">\n                                                <div class=\"text-graph-row\">\n                                                    <div class=\"column-1\">\n                                                                                                                        <div class=\"text-graph-img visible\">\n                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101346\/ONCOLOGY_PICTO_72x72pix.jpg\" alt=\"Un portefeuille robuste de produits en oncologie\" title=\"Un portefeuille robuste de produits en oncologie\" \/> \n                                                                                                                                    <\/div>\n                                                                                                            <\/div>\n                                                    <div class=\"column-2\">\n                                                        <div class=\"text-graph-content\">\n                                                            <div class=\"text-graph-title\">\n                                                                <h3>Un portefeuille robuste de produits en oncologie<\/h3>\n                                                            <\/div>\n                                                            <div class=\"text-graph-desc\">\n                                                                <p><p>Ipsen poss\u00e8de six actifs mis \u00e0 disposition des personnes atteintes d&#8217;un cancer dans le monde.<\/p>\n<\/p>\n                                                            <\/div>\n                                                        <\/div>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                                                                                                                                            <div class=\"text-graphic\">\n                                                <div class=\"text-graph-row\">\n                                                    <div class=\"column-1\">\n                                                                                                                        <div class=\"text-graph-img visible\">\n                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101410\/EXPERIENCEE_PICTO_72x72pix-1.jpg\" alt=\"Plus de 35 ans d'exp\u00e9rience en oncologie\" title=\"Plus de 35 ans d'exp\u00e9rience en oncologie\" \/> \n                                                                                                                                    <\/div>\n                                                                                                            <\/div>\n                                                    <div class=\"column-2\">\n                                                        <div class=\"text-graph-content\">\n                                                            <div class=\"text-graph-title\">\n                                                                <h3>Plus de 35 ans d&#8217;exp\u00e9rience en oncologie<\/h3>\n                                                            <\/div>\n                                                            <div class=\"text-graph-desc\">\n                                                                <p><p>Ipsen est un acteur de l&#8217;oncologie depuis 1986. Notre portefeuille comprend aujourd&#8217;hui des traitements pour les cancers du rein, du foie, de la thyro\u00efde, du pancr\u00e9as, de la prostate et du sein, ainsi que les tumeurs neuroendocrines, le lymphome folliculaire et le sarcome \u00e9pith\u00e9lio\u00efde.<\/p>\n<\/p>\n                                                            <\/div>\n                                                        <\/div>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                                                                                                                                            <div class=\"text-graphic\">\n                                                <div class=\"text-graph-row\">\n                                                    <div class=\"column-1\">\n                                                                                                                        <div class=\"text-graph-img visible\">\n                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101438\/WORLDWIDE_PICTO_72x72pix.jpg\" alt=\"Cancer du rein\" title=\"Cancer du rein\" \/> \n                                                                                                                                    <\/div>\n                                                                                                            <\/div>\n                                                    <div class=\"column-2\">\n                                                        <div class=\"text-graph-content\">\n                                                            <div class=\"text-graph-title\">\n                                                                <h3>Cancer du rein<\/h3>\n                                                            <\/div>\n                                                            <div class=\"text-graph-desc\">\n                                                                <p><p>Plus de 400 000 nouveaux cas de cancer du rein sont diagnostiqu\u00e9s chaque ann\u00e9e dans le monde. 90 % d&#8217;entre eux sont des carcinomes \u00e0 cellules r\u00e9nales (RCC). Jusqu&#8217;\u00e0 30 % des patients pr\u00e9sentent, au moment du diagnostic, un RCC avanc\u00e9 ou m\u00e9tastatique.<\/p>\n<\/p>\n                                                            <\/div>\n                                                        <\/div>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                                                                                                                                            <div class=\"text-graphic\">\n                                                <div class=\"text-graph-row\">\n                                                    <div class=\"column-1\">\n                                                                                                                        <div class=\"text-graph-img visible\">\n                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101502\/PARTNERSHIP_PICTO_72x72pix.jpg\" alt=\"Investir dans l'avenir de l'oncologie \" title=\"Investir dans l'avenir de l'oncologie \" \/> \n                                                                                                                                    <\/div>\n                                                                                                            <\/div>\n                                                    <div class=\"column-2\">\n                                                        <div class=\"text-graph-content\">\n                                                            <div class=\"text-graph-title\">\n                                                                <h3>Investir dans l&#8217;avenir de l&#8217;oncologie <\/h3>\n                                                            <\/div>\n                                                            <div class=\"text-graph-desc\">\n                                                                <p><p>Nous sommes pionniers de plusieurs traitements novateurs et construisons notre portefeuille de produits en R&amp;D gr\u00e2ce \u00e0 l&#8217;innovation externe. En 2021, nous avons nou\u00e9 sept partenariats et int\u00e9gr\u00e9 huit nouveaux actifs. En 2022, nous avons acquis Epizyme, ce qui nous a permis d&#8217;\u00e9tendre notre portefeuille oncologique \u00e0 l&#8217;h\u00e9matologie. Notre objectif est d&#8217;ajouter plusieurs nouveaux traitements \u00e0 notre portefeuille de produits en R&amp;D d&#8217;ici 2025, en innovant aux c\u00f4t\u00e9s de nos partenaires.<\/p>\n<\/p>\n                                                            <\/div>\n                                                        <\/div>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                                                                                            <\/div>\n                            <\/div>\n                                            <\/div> <!-- graphic-card carousel end here -->\n                <\/div> <!--Graphic detail section over here with 12 grid -->   \n            <\/div><!--row ended here-->\n        <\/div> <!-- graph-inner ended here -->\n        \n            <div class=\"more-result-btn\">\n                                            <\/div>\n        <\/div> <!--Container class ended here -->\n    <\/section>\n<!--Graphics Cards Carousel End Here-->\n\n\n \n\n\n    <!--Accordion Cards Start Here-->\n    <section class=\"accordion\" data-according-id=\"1895695866\">\n        <div class=\"container\">\n            <div class=\"row\">\n                <!--Accordion info section-->\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                    <div class=\"accordian-info\">\n                        <h2 class=\"accordian-heading visible\">Notre expertise en oncologie<\/h3>\n                        <p class=\"accordian-summary visible\">Avec plus de 35 ans d&#8217;expertise dans les th\u00e9rapies contre le cancer, l&#8217;oncologie repr\u00e9sente la plus grande aire th\u00e9rapeutique d&#8217;Ipsen.<\/p>\n                    <\/div>\n                <\/div><!--Accordion info section over here -->\n\n                <div class=\"col-xl-12 col-lg-12 col-md-12 col-sm-12\">\n                    <div class=\"accordion accor-group\" id=\"accordionExample1895695866\">\n                         \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading0\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading18956958660\" aria-expanded=\"true\" aria-controls=\"expHeading18956958660\">\n                                                Le  carcinome du rein (RCC) avanc\u00e9                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading18956958660\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading0\" data-bs-parent=\"#accordionExample1895695866\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Plus de 400 000 nouveaux cas de cancer du rein sont diagnostiqu\u00e9s chaque ann\u00e9e dans le monde, dont 90\u00a0% sont des carcinomes du rein (RCC). Au moment du diagnostic, jusqu&#8217;\u00e0 30 % des patients pr\u00e9sentent un RCC avanc\u00e9 ou m\u00e9tastatique. S\u2019il est d\u00e9tect\u00e9 au stade pr\u00e9coce, le taux de survie \u00e0 cinq ans est \u00e9lev\u00e9. Pour les patients atteints d\u2019un RCC localement avanc\u00e9 ou \u00e0 un stade avanc\u00e9 m\u00e9tastatique, le taux de survie \u00e0 cinq ans est beaucoup plus faible, autour de 12\u00a0%.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading1\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading18956958661\" aria-expanded=\"true\" aria-controls=\"expHeading18956958661\">\n                                                Le cancer du sein                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading18956958661\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading1\" data-bs-parent=\"#accordionExample1895695866\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le cancer du sein est le cancer le plus r\u00e9pandu dans le monde et le plus fr\u00e9quent chez la femme; 65 \u00e0 75 % des cancers du sein sont hormonosensibles.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading2\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading18956958662\" aria-expanded=\"true\" aria-controls=\"expHeading18956958662\">\n                                                Le sarcome \u00e9pith\u00e9lio\u00efde                                             <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading18956958662\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading2\" data-bs-parent=\"#accordionExample1895695866\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le sarcome \u00e9pith\u00e9lio\u00efde est un cancer rare appel\u00e9 sarcome des tissus mous. Il se manifeste par une excroissance de cellules dans les tissus mous et peut appara\u00eetre n&#8217;importe o\u00f9 sur le corps. Dans la plupart des cas, le sarcome \u00e9pith\u00e9lio\u00efde se d\u00e9veloppe dans les tissus mous sous la peau d\u2019un doigt, d\u2019une main, d\u2019un avant-bras, d&#8217;un genou ou d\u2019une jambe. Il provoque la formation d&#8217;une ou plusieurs petites excroissances ou grosseurs sous la peau, et peut souvent \u00eatre confondu avec d&#8217;autres pathologies. Plusieurs excroissances peuvent appara\u00eetre jusqu&#8217;\u00e0 ce que la personne touch\u00e9e demande un avis m\u00e9dical . Le sarcome \u00e9pith\u00e9lio\u00efde affecte le plus souvent les adolescents et les jeunes adultes, mais peut \u00e9galement toucher les personnes plus \u00e2g\u00e9es. Le sarcome des tissus mous repr\u00e9sente environ 1 % des cancers chez l&#8217;adulte. Le sarcome \u00e9pith\u00e9lio\u00efde repr\u00e9sente environ 1 % des sarcomes des tissus mous recens\u00e9s chaque ann\u00e9e aux \u00c9tats-Unis.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading3\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading18956958663\" aria-expanded=\"true\" aria-controls=\"expHeading18956958663\">\n                                                Le lymphome folliculaire                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading18956958663\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading3\" data-bs-parent=\"#accordionExample1895695866\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le lymphome folliculaire est un type de lymphome non hodgkinien (NHL), qui est un cancer du syst\u00e8me lymphatique. Il se manifeste lorsque le corps produit des lymphocytes B anormaux. Ces lymphocytes sont un type de globule blanc qui aide normalement \u00e0 combattre les infections. Lorsqu&#8217;un patient a un lymphome, les lymphocytes anormaux s&#8217;accumulent dans les ganglions lymphatiques ou d&#8217;autres organes. Entre 15 000 et 20 000 cas de lymphome folliculaire sont diagnostiqu\u00e9s chaque ann\u00e9e aux \u00c9tats-Unis. La plupart des diagnostics sont \u00e9tablis \u00e0 des stades avanc\u00e9s.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading4\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading18956958664\" aria-expanded=\"true\" aria-controls=\"expHeading18956958664\">\n                                                Le carcinome h\u00e9patocellulaire                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading18956958664\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading4\" data-bs-parent=\"#accordionExample1895695866\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le carcinome h\u00e9patocellulaire est aussi appel\u00e9 h\u00e9patome ou CHC. Il s&#8217;agit du type le plus courant de cancer primitif du foie. Ce type de cancer du foie se d\u00e9veloppe au niveau des principales cellules du foie, appel\u00e9es h\u00e9patocytes. Il est plus fr\u00e9quent chez les personnes atteintes de cirrhose, lorsque le foie pr\u00e9sente des l\u00e9sions cicatricielles notamment caus\u00e9es par le virus de l\u2019h\u00e9patite B ou C, ou par l\u2019exc\u00e8s d\u2019alcool \u00e0 long terme. Plus de 900 000 nouveaux cas de cancer du foie, dont 90 % de CHC, sont diagnostiqu\u00e9s dans le monde chaque ann\u00e9e. Le CHC devrait causer 1 million de d\u00e9c\u00e8s par an dans le monde d&#8217;ici 2030.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading5\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading18956958665\" aria-expanded=\"true\" aria-controls=\"expHeading18956958665\">\n                                                Les tumeurs neuroendocrines et le syndrome carcino\u00efde                                             <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading18956958665\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading5\" data-bs-parent=\"#accordionExample1895695866\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Les tumeurs neuroendocrines, ou TNE, sont un groupe de tumeurs rares qui se d\u00e9veloppent \u00e0 partir des cellules du syst\u00e8me neuroendocrinien, dispers\u00e9es dans tout le corps. Les TNE surviennent aussi bien chez les hommes que chez les femmes, en g\u00e9n\u00e9ral \u00e2g\u00e9s de 50 \u00e0 60 ans, bien qu\u2019elles puissent affecter des personnes de tout \u00e2ge . Les trois principales zones du corps affect\u00e9es par les TNE sont le tractus gastro-intestinal, le pancr\u00e9as et les poumons. 171 000 personnes sont atteintes de TNE aux \u00c9tats-Unis. Le nombre total de nouveaux cas de TNE devrait augmenter dans les ann\u00e9es \u00e0 venir. Cette hausse est principalement due \u00e0 une sensibilisation accrue aux TNE et aux tests de d\u00e9pistage. Les patients atteints de TNE attendent jusqu&#8217;\u00e0 sept ans en moyenne pour recevoir un diagnostic.<\/p>\n<p>&nbsp;<\/p>\n<p>Les tumeurs neuroendocrines sont parfois appel\u00e9es tumeurs carcino\u00efdes, en particulier lorsqu&#8217;elles affectent l&#8217;intestin gr\u00eale, le gros intestin ou l&#8217;appendice. Le syndrome carcino\u00efde d\u00e9signe l&#8217;ensemble des sympt\u00f4mes que certaines personnes atteintes d&#8217;une tumeur neuroendocrine peuvent ressentir. Il est plus fr\u00e9quent lorsque la tumeur s&#8217;est propag\u00e9e au foie et que des hormones telles que la s\u00e9rotonine passent dans la circulation sanguine. Bien que le syndrome carcino\u00efde puisse survenir chez les personnes atteintes de tumeurs neuroendocrines pulmonaires et pancr\u00e9atiques, ce cas est g\u00e9n\u00e9ralement rare.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading6\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading18956958666\" aria-expanded=\"true\" aria-controls=\"expHeading18956958666\">\n                                                Le cancer du pancr\u00e9as                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading18956958666\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading6\" data-bs-parent=\"#accordionExample1895695866\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le cancer du pancr\u00e9as est une maladie syst\u00e9mique agressive dont l&#8217;incidence continue de cro\u00eetre et qui devrait devenir la deuxi\u00e8me cause la plus fr\u00e9quente de d\u00e9c\u00e8s li\u00e9s au cancer d&#8217;ici 2030 . Le cancer du pancr\u00e9as peut \u00eatre difficile \u00e0 diagnostiquer en raison du manque de tests de d\u00e9pistage sp\u00e9cifiques valid\u00e9s, permettant de d\u00e9tecter facilement et de mani\u00e8re fiable un cancer du pancr\u00e9as \u00e0 un stade pr\u00e9coce chez les personnes qui ne pr\u00e9sentent aucun sympt\u00f4me. Les personnes atteintes d&#8217;un cancer du pancr\u00e9as ne pr\u00e9sentent souvent aucun sympt\u00f4me aux premiers stades de la maladie, ce qui signifie que ce cancer n&#8217;est souvent d\u00e9tect\u00e9 qu&#8217;\u00e0 des stades plus avanc\u00e9s, lorsque le cancer ne peut plus \u00eatre retir\u00e9 gr\u00e2ce \u00e0 la chirurgie et\/ou s&#8217;est propag\u00e9 depuis le pancr\u00e9as vers d&#8217;autres parties du corps. Il s&#8217;agit de la troisi\u00e8me cause de d\u00e9c\u00e8s li\u00e9 au cancer aux \u00c9tats-Unis.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading7\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading18956958667\" aria-expanded=\"true\" aria-controls=\"expHeading18956958667\">\n                                                Le cancer de la prostate                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading18956958667\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading7\" data-bs-parent=\"#accordionExample1895695866\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le cancer de la prostate se d\u00e9veloppe g\u00e9n\u00e9ralement lentement, de sorte qu&#8217;il ne peut y avoir aucun sympt\u00f4me pendant de nombreuses ann\u00e9es. Plus de 1,4 million de nouveaux cas de cancer de la prostate ont \u00e9t\u00e9 diagnostiqu\u00e9s dans le monde en 2020. Il s&#8217;agit du quatri\u00e8me cancer le plus fr\u00e9quent dans la population mondiale et du deuxi\u00e8me cancer le plus fr\u00e9quent chez l&#8217;homme.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading8\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading18956958668\" aria-expanded=\"true\" aria-controls=\"expHeading18956958668\">\n                                                Le cancer de la thyro\u00efde diff\u00e9renci\u00e9 r\u00e9fractaire \u00e0 l&#8217;iode radioactif                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading18956958668\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading8\" data-bs-parent=\"#accordionExample1895695866\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>En 2020, plus de 580 000 nouveaux cas de cancer de la thyro\u00efde ont \u00e9t\u00e9 diagnostiqu\u00e9s dans le monde. Le cancer de la thyro\u00efde est le neuvi\u00e8me cancer le plus fr\u00e9quent \u00e0 l\u2019\u00e9chelle mondiale. Son incidence est trois fois plus \u00e9lev\u00e9e chez les femmes que chez les hommes. Les tumeurs canc\u00e9reuses de la thyro\u00efde ont des formes diff\u00e9renci\u00e9es, m\u00e9dullaires ou anaplasiques. Le cancer de la thyro\u00efde diff\u00e9renci\u00e9 (DTC) repr\u00e9sente environ 90 \u00e0 95 % des cas. Le DTC est g\u00e9n\u00e9ralement trait\u00e9 par chirurgie, suivie d\u2019une ablation du tissu thyro\u00efdien restant par traitement \u00e0 l\u2019iode radioactif (RAI), mais environ 5 \u00e0 15 % des cancers r\u00e9sistent au traitement par RAI. Les patients qui d\u00e9veloppent un DTC r\u00e9fractaire \u00e0 l\u2019iode radioactif (RAI-R) ont une dur\u00e9e de survie m\u00e9diane estim\u00e9e de trois \u00e0 cinq ans.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                                                <\/div>\n                <\/div> \n            <\/div>\n        <\/div>\n    <\/section>\n    <!--Accordion Cards End Here-->\n\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row \">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 \">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101617\/Module-9_Oncology-clinical-trial_191209_0729.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 \">\n                        <div class=\" section-content\">\n                                                                                            <h3 class=\"section-head-two\">\n                                        Les essais cliniques d&#8217;Ipsen en oncologie                                     <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        \u00a0Nous travaillons sans rel\u00e2che pour amener de nouveaux traitements au stade d&#8217;essai clinique et ainsi r\u00e9pondre aux besoins m\u00e9dicaux non satisfaits des patients.                                     <\/p>\n                                                                                                <a \n                                            role=\"link\" \n                                            class=\"btn-link section-btn cta-visible\" \n                                            href=\"https:\/\/www.ipsen.com\/fr\/essais-cliniques\/\" \n                                            aria-label=\"Learn more about \" \n                                            target=\"_blank\"\n                                        >\n                                            En savoir plus                                         <\/a>    \n                                    <\/button>\n                                                    <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row section-bg-reverse\">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 order-2\">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101641\/Module-10_Oncology-pipeline_191209_1833.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 order-1\">\n                        <div class=\" section-content\">\n                                                                                            <h3 class=\"section-head-two\">\n                                        Notre portefeuille de produits en R&amp;D                                    <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        Aux c\u00f4t\u00e9s de partenaires qui partagent notre vision, nous mettons tout en \u0153uvre pour am\u00e9liorer le quotidien des patients et de leurs aidants. Nos \u00e9quipes s&#8217;emploient jour apr\u00e8s jour \u00e0 apporter les meilleures options de traitement possibles aux patients&#8230;                                    <\/p>\n                                                                                                <a \n                                            role=\"link\" \n                                            class=\"btn-link section-btn cta-visible\" \n                                            href=\"https:\/\/www.ipsen.com\/fr\/portefeuille-de-produits-r-et-d\/\" \n                                            aria-label=\"Learn more about \" \n                                            target=\"_blank\"\n                                        >\n                                            En savoir plus                                         <\/a>    \n                                    <\/button>\n                                                    <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-94","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nous consacrons nos efforts \u00e0 l&#039;am\u00e9lioration de l&#039;\u00e9tat de sant\u00e9 des personnes atteintes d&#039;un cancer<\/title>\n<meta name=\"description\" content=\"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nous consacrons nos efforts \u00e0 l&#039;am\u00e9lioration de l&#039;\u00e9tat de sant\u00e9 des personnes atteintes d&#039;un cancer\" \/>\n<meta property=\"og:description\" content=\"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/\" \/>\n<meta property=\"og:site_name\" content=\"Belgium\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-10T09:08:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/\",\"url\":\"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/\",\"name\":\"Nous consacrons nos efforts \u00e0 l'am\u00e9lioration de l'\u00e9tat de sant\u00e9 des personnes atteintes d'un cancer\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#website\"},\"datePublished\":\"2023-12-22T04:50:36+00:00\",\"dateModified\":\"2024-04-10T09:08:58+00:00\",\"description\":\"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/be\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncologie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#website\",\"url\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/\",\"name\":\"Belgium\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#organization\",\"name\":\"Belgium\",\"url\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2023\/12\/07165829\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2023\/12\/07165829\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"Belgium\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nous consacrons nos efforts \u00e0 l'am\u00e9lioration de l'\u00e9tat de sant\u00e9 des personnes atteintes d'un cancer","description":"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/","og_locale":"fr_FR","og_type":"article","og_title":"Nous consacrons nos efforts \u00e0 l'am\u00e9lioration de l'\u00e9tat de sant\u00e9 des personnes atteintes d'un cancer","og_description":"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.","og_url":"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/","og_site_name":"Belgium","article_modified_time":"2024-04-10T09:08:58+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/","url":"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/","name":"Nous consacrons nos efforts \u00e0 l'am\u00e9lioration de l'\u00e9tat de sant\u00e9 des personnes atteintes d'un cancer","isPartOf":{"@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#website"},"datePublished":"2023-12-22T04:50:36+00:00","dateModified":"2024-04-10T09:08:58+00:00","description":"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/be\/fr\/oncologie\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/be\/fr\/oncologie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/be\/fr\/"},{"@type":"ListItem","position":2,"name":"Oncologie"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#website","url":"https:\/\/www.ipsen.com\/be\/fr\/en\/","name":"Belgium","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/be\/fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#organization","name":"Belgium","url":"https:\/\/www.ipsen.com\/be\/fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2023\/12\/07165829\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2023\/12\/07165829\/Latest_Ipsen-logo_168x48.svg","caption":"Belgium"},"image":{"@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/pages\/94","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/comments?post=94"}],"version-history":[{"count":9,"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/pages\/94\/revisions"}],"predecessor-version":[{"id":1152,"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/pages\/94\/revisions\/1152"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/media?parent=94"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}